Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in February, 2021 for $253,385.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI156961-01 | Phase I | 253,385 | February 2, 2021 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in January, 2020 for $242,610.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI150530-01 | Phase I | 242,610 | January 17, 2020 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in May, 2019 for $242,611.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232276-01A1 | Phase I | 242,611 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in August, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001128-01A1 | Phase I | 225,000 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in September, 2019 for $242,611.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA235891-01A1 | Phase I | 242,611 | September 3, 2019 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in August, 2022 for $258,109.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY034054-01 | Phase I | 258,109 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in August, 2015 for $242,611.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA200198-01 | Phase I | 242,611 | August 15, 2015 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in January, 2017 for $242,611.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI129078-01 | Phase I | 242,611 | January 3, 2017 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in July, 2015 for $242,611.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA189335-01A1 | Phase I | 242,611 | July 16, 2015 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in September, 2017 for $242,611.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA221412-01 | Phase I | 242,611 | September 18, 2017 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. for $913,399.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI090852-01 | Phase I | 913,399 | ||||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. for $196,199.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI081511-01 | Phase I | 196,199 |